UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023092
Receipt number R000026614
Scientific Title Effects of Intensive Rehabilitation after Botulinum Toxin Type A Injection on Gait in Chronic Post-Stroke Patients
Date of disclosure of the study information 2016/07/10
Last modified on 2016/07/10 02:30:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of Intensive Rehabilitation after Botulinum Toxin Type A Injection on Gait in Chronic Post-Stroke Patients

Acronym

Effects of Rehabilitation after Botulinum Toxin Type A Injection

Scientific Title

Effects of Intensive Rehabilitation after Botulinum Toxin Type A Injection on Gait in Chronic Post-Stroke Patients

Scientific Title:Acronym

Effects of Rehabilitation after Botulinum Toxin Type A Injection

Region

Japan


Condition

Condition

Stroke

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aim to examine the effects of intensive rehabilitation following botulinum toxin type A injection on gait for patients with lower-limb spasticity.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The modified Ashworth scale of ankle plantar flexor, range of motion of ankle dorsiflexion, 10-meter walking test, 6-minute walking distance test, timed up and go test, and Berg balance scale at every 2-week follow-up after BoNT-A injection.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

post-stroke hemiparesis, lower-limb spasticity causing gait disturbance, 6 months or more after stroke onset, spastic drop foot by a score of 2 or more for ankle flexors on the modified Ashworth scale, no history of BoNT-A injection for lower-limb spasticity, gait assessed by functional independence measure score 5 or more.

Key exclusion criteria

No remarkable higher brain dysfunction affecting gait disturbance.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kazuhisa Domen

Organization

Hyogo College of Medicine

Division name

Department of Rehabilitation Medicine

Zip code


Address

1-1 Mukogawa-cho, Nishinomiya, Hyogo

TEL

0798-45-6881

Email

domen@hyo-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yuki Uchiyama

Organization

Sasayama Medical Center, Hyogo College of Medicine

Division name

Department of Rehabilitation Medicine

Zip code


Address

Kuro-oka 5, Sasayama, Hyogo

TEL

079-552-1181

Homepage URL


Email

yutti@hyo-med.ac.jp


Sponsor or person

Institute

Hyogo College of Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

兵庫医科大学ささやま医療センター


Other administrative information

Date of disclosure of the study information

2016 Year 07 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2016 Year 07 Month 10 Day

Date of IRB


Anticipated trial start date

2016 Year 07 Month 10 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Analyses showed statistically significant improvements in 10-meter walking test(10MWT) and 6-minute walking distance test(6MD) for both groups. In group II, the 10MWT and 6MD improved much more during the last 4 weeks after BoNT-A injection than during the first 4 weeks before BoNT-A injection.


Management information

Registered date

2016 Year 07 Month 10 Day

Last modified on

2016 Year 07 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026614


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name